What Shapes a Choice: Behavioral and Systemic Determinants of Radioligand Therapy Adoption in Prostate Cancer Care

OSF Preprints (OSF Preprints) 2026 Preprint

Authors: Dicla Veliz Salce
Cited by: 0

Abstract

Qualitative systematic review that aims to examine the behavioural, contextual, and system-level factors that influence the adoption of PSMA-targeted radioligand therapy (Pluvicto) for metastatic castration-resistant prostate cancer (mCRPC) in real-world clinical settings.

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research

Publication details

Journal / source
OSF Preprints (OSF Preprints)
Publication date
15 February 2026
Language
EN
Document type
Preprint